SILO · Silo Pharma
AI read · Neutral
The AI's read
No sales and a slightly larger operating loss point to continued difficulty bringing in money. The loss per share was smaller, but the report gives no reason for that change. These figures point in different directions and do not show a clear change in Silo Pharma's outlook.